RAC 0.65% $1.56 race oncology ltd

Cardioprotection thread, page-739

  1. 1,059 Posts.
    lightbulb Created with Sketch. 11708
    You are terrified

    The equivalent of $300M AUD worth of clinical trials if completed today that led to Bisantrene being approved for use in the 90s and all valid for commercialization and approval this decade.

    Why did they use an 80% confidence interval for HERVAXX when Herceptin was always reported at 95% confidence?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.